Article
Linc00312 Single Nucleotide Polymorphism as Biomarker for Chemoradiotherapy Induced Hematotoxicity in Nasopharyngeal Carcinoma Patients.
Disease markers - 1 Jan 2022
Guo Zhen, Wang Ya-Jing, He Bin-Sheng, Zhou Ji
Abstract excerpt
Background: Linc00312 is downregulated in nasopharyngeal carcinoma (NPC) and associates with poor treatment efficacy. Genetic variations are the main cause of individual differences in treatment response. The objective of this study is to explore the relationship between genetic variations of linc00312 and the risk of chemoradiotherapy induced toxic reactions in NPC patients. Methods: We used a bioinformatics...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
